Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7 | 16 | 5 | 8 | N/A |
| Receivables | 22 | 127 | 11 | 38 | 8 |
| Inventories | 54 | 47 | 5 | N/A | 118 |
| TOTAL | $350 | $342 | $89 | $247 | $158 |
| Non-Current Assets | |||||
| PPE Net | 19 | 30 | 25 | 40 | 55 |
| Other Non-Current Assets | 19 | 16 | 16 | 17 | 17 |
| TOTAL | $38 | $45 | $41 | $56 | $71 |
| Total Assets | $388 | $387 | $129 | $303 | $229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,492 | 961 | 1,359 | 1,372 | 1,212 |
| Accounts payable and accrued liabilities | 989 | 1,785 | 1,709 | 1,524 | 1,949 |
| Accrued Expenses | 1,130 | 1,020 | 958 | 965 | 951 |
| Other current liabilities | 143 | 187 | 323 | 19 | 29 |
| TOTAL | $3,754 | $3,952 | $4,349 | $3,879 | $4,141 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 208 | 30 | 0 | 0 | 0 |
| TOTAL | $208 | $30 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,962 | $3,982 | $4,349 | $3,879 | $4,141 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,895 | 37,799 | 26,407 | 14,735 | 13,053 |
| Common Shares | 80 | 37 | 1,004 | 562 | 326 |
| Retained earnings | -49,912 | -44,520 | -41,987 | -37,644 | -34,032 |
| TOTAL | $-3,574 | $-3,595 | $-4,219 | $-3,576 | $-3,911 |
| Total Liabilities And Equity | $388 | $387 | $129 | $303 | $229 |